We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Aetna (AET) Beats Q4 Earning Estimates, Guides for 2017
Read MoreHide Full Article
Aetna Inc. is one of the nation's leading diversified healthcare benefits companies.
Aetna with its strong business, a diversified revenue stream should benefit in this changing environment.
Aetna’s pending acquisition of Humana Inc. (HUM - Free Report) was recently blocked by the regulators. Notwithstanding the latest hit to the merger, Aetna is planning to appeal the case. It also has some back up plans. It may look to expand in Medicaid, by way of acquiring Medicaid-centric companies.
Aetna has a pretty good earnings track record with the company delivering positive earnings surprises in each of the last four quarters with an average surprise of 6.25%.
Currently, Aetna has a Zacks Rank #4 (Sell), but that could definitely change following the company’s earnings report which was just released. You can see the complete list of today’s Zacks #1 Rank stocks here We have highlighted some of the key stats from this just-revealed announcement below:
The Bottom Line: Aetna beats on earnings. Our consensus called for EPS of $1.45 and the company reported earnings per share of $1.63 and increased 19% year over year.
The Top Line: Revenues missed expectations. Aetna posted operating revenues of $15.72 billion, a tad lower than our consensus estimate of $15.9 billion, but grew 5% year over year.
Key Stats: Adjusted operating expense ratio was 19.8% down 70 basis points year over year.
Medical membership totaled 23.1 million at Dec 31, 2016.
2017 Guidance
The company expects 2017 operating earnings of ‘at least $8.55’ per share.
Check back later for our full write up on this AET earnings report later!
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?
Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Aetna (AET) Beats Q4 Earning Estimates, Guides for 2017
Aetna Inc. is one of the nation's leading diversified healthcare benefits companies.
Aetna with its strong business, a diversified revenue stream should benefit in this changing environment.
Aetna’s pending acquisition of Humana Inc. (HUM - Free Report) was recently blocked by the regulators. Notwithstanding the latest hit to the merger, Aetna is planning to appeal the case. It also has some back up plans. It may look to expand in Medicaid, by way of acquiring Medicaid-centric companies.
Aetna has a pretty good earnings track record with the company delivering positive earnings surprises in each of the last four quarters with an average surprise of 6.25%.
Currently, Aetna has a Zacks Rank #4 (Sell), but that could definitely change following the company’s earnings report which was just released. You can see the complete list of today’s Zacks #1 Rank stocks here We have highlighted some of the key stats from this just-revealed announcement below:
The Bottom Line: Aetna beats on earnings. Our consensus called for EPS of $1.45 and the company reported earnings per share of $1.63 and increased 19% year over year.
The Top Line: Revenues missed expectations. Aetna posted operating revenues of $15.72 billion, a tad lower than our consensus estimate of $15.9 billion, but grew 5% year over year.
Aetna Inc. Price and EPS Surprise
Aetna Inc. Price and EPS Surprise | Aetna Inc. Quote
Key Stats: Adjusted operating expense ratio was 19.8% down 70 basis points year over year.
Medical membership totaled 23.1 million at Dec 31, 2016.
2017 Guidance
The company expects 2017 operating earnings of ‘at least $8.55’ per share.
Check back later for our full write up on this AET earnings report later!
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?
Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>